India Launches First National Guidelines for Childhood Diabetes Care India has taken a major step toward strengthening child healthcare with the launch of its first-ever national guidelines for managing Childhood Diabetes. Issued by the Health Ministry, the framework aims to ensure early detection, effective treatment, and long-term
India Launches First National Guidelines for Childhood Diabetes Care India has taken a major step toward strengthening child healthcare with the launch of its first-ever national guidelines for managing Childhood Diabetes. Issued by the Health Ministry, the framework aims to ensure early detection, effective treatment, and long-term
India’s pharmaceutical industry is poised for a massive shift as the patent for semaglutide, the active ingredient behind blockbuster drugs like Ozempic and Wegovy, expires on March 20, 2026. This marks the beginning of what experts are calling an unprecedented "generic wave". Within days, over 50 branded generic versions of semaglutide are expected to flood the Indian market, sparking one of the most significant pharmaceutical launches in recent history.
India’s pharmaceutical industry is poised for a massive shift as the patent for semaglutide, the active ingredient behind blockbuster drugs like Ozempic and Wegovy, expires on March 20, 2026. This marks the beginning of what experts are calling an unprecedented "generic wave". Within days, over 50 branded generic versions of semaglutide are expected to flood the Indian market, sparking one of the most significant pharmaceutical launches in recent history.